photo
Speaker

Sally Wang Liang, Esq;JD;MPH

SENIOR VICE PRESIDENT, BUSINESS DEVELOPMENT, ZONSEN PEPLIB BIOTECH LTD.
Boston, Massachusetts, United States
Sally Wang Liang JD MPH is VP of Business Development, Head of the Global Business Unit at PepLib, a peptide discovery and therapeutics company with a proprietary screening platform with functional assay and membrane protein screening capabilities. She leads a global BD team in all aspects of deal-making and led the recently closed major pharma collaboration.

She comes to PepLib as a life sciences business executive and a multidisciplinary IP & Regulatory lawyer with 15+ years of healthcare industry experience. She is actively involved in the biotech ecosystem: consults as a Venture Partner at Viva Bioinnovator (VBI), sitting on the boards of three biotechs, Scientific Advisory Board member of New Equilibrium Biosciences, Expert-in-Residence at the Harvard iLab, and mentor with MassBIO and Activate-Nucleate.
Speaking In
3:30 PM - 3:45 PM (PDT)
Tuesday, June 14
PepLib is rethinking peptide drug discovery. PepLib’s platform, powered by Peptide Information…